SCIENTURE HOLDINGS, INC. Transfer to Investments
SCIENTURE HOLDINGS, INC. (SCNX) reported Transfer to Investments of $0 for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-10-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:TransferToInvestments · last filed 2018-10-26
- SCIENTURE HOLDINGS, INC. transfer to investments for the quarter ending 2018-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. transfer to investments for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. transfer to investments for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- SCIENTURE HOLDINGS, INC. transfer to investments for the quarter ending 2017-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. transfer to investments for fiscal 2017 was $32.55K.
- SCIENTURE HOLDINGS, INC. transfer to investments for fiscal 2016 was $0.00.
| Period end | Transfer to Investments 3 month | Transfer to Investments 6 month | Transfer to Investments 9 month | Transfer to Investments 12 month |
|---|---|---|---|---|
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $0.00 derived: sum of 2 quarters · filed 2018-10-26 | $0.00 10-Q · filed 2018-10-26 | $0.00 derived: sum of 4 quarters · filed 2018-10-26 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $0.00 10-Q · filed 2018-07-27 | $0.00 derived: sum of 3 quarters · filed 2018-07-27 | $0.00 derived: sum of 4 quarters · filed 2018-10-26 |
| 2018-03-31 | $0.00 10-Q · filed 2018-04-27 | $0.00 derived: sum of 2 quarters · filed 2018-04-27 | $0.00 derived: sum of 3 quarters · filed 2018-10-26 | $25.27K derived: sum of 4 quarters · filed 2018-10-26 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-10-26 | $25.27K derived: sum of 3 quarters · filed 2018-10-26 | $32.55K 10-K · filed 2018-03-02 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26 | $25.27K derived: sum of 2 quarters · filed 2018-10-26 | $32.55K 10-Q · filed 2018-10-26 | $32.55K derived: sum of 4 quarters · filed 2018-10-26 |
| 2017-06-30 | $25.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $32.55K 10-Q · filed 2018-07-27 | $32.55K derived: sum of 3 quarters · filed 2018-07-27 | $32.55K derived: sum of 4 quarters · filed 2018-07-27 |
| 2017-03-31 | $7.28K 10-Q · filed 2018-04-27 | $7.28K derived: sum of 2 quarters · filed 2018-04-27 | $7.28K derived: sum of 3 quarters · filed 2018-04-27 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 derived: sum of 2 quarters · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |